|
Стр. 12
blind placebo-controlled trial of thrombolytic therapy with
intravenous alteplase in acute ischaemic stroke (ECASS II). Second
European Australasian Acute Stroke Study Investigators // Lancet.
- 1998. - 352. - P. 1245-1251.
71. Hacke W., Kaste M., Olsen T.S., Orgogozo J.-M.,
Bogousslavsky J. European Stroke Initiative: recommendations for
stroke management. Organization of stroke care // J. Neurol.. -
2000. - P. 732-748.
72. Hacke W., Schwab S., Horn M. et al. "Malignant" middle
cerebral artery territory infarction: clinical course and
prognostic signs // Arch Neurol. - 1996. - 53. - p. 309-315.
73. Handbook of Cerebrovascular Diseases. Adams H.P. (Ed.). -
N.-Y.: Marcel Dekker, 1993. - P. 655-672.
74. Hankey C, Hon C. Surgery for primary intracerebral
hemorrhage: is it safe and effective? A systematic review of case
series and randomised trials // Stroke. - 1997. - 28. - P.
2126-2123.
75. Hart R.G., Pearce L.A., Rothbart R.M., McAnulty J.H.,
Asinger R.W., Halperin J.L. Stroke with intermittent atrial
fibrillation: incidence and predictos during aspirin therapy.
Stroke Prevention in Atrial fibrillation Investigators // J. Amer.
Coll, Cardiol. - 2000. - 35. - P. 183-187.
76. Hemodilution in Stroke Study Group. Hypervolemic
hemodilution treatment of acute stroke. Results of a randomized
multicenler trial using pentastarch // Stroke. - 1989. - 20. - P.
317-323.
77. Heros R. Surgical treatment of cerebellar infarction //
Stroke. - 1992. - 23. - P. 937-938.
78. Horn J., Haas R., Vemuelen M., Limburg M. VENUS - Very
early nimodipine use in stroke: preliminary trial results //
Stroke. - 1999. - 30. - Abstr: 242.
79. Horn J., Limburg M. Calcium antagonists for acute ischemic
stroke // In: The Cochrane Library, Issue 3, 2000. Oxford: Update
Software. Search date January 1999.
80. Horn J., Orgogozo J.M., Limburg M. Review on calcium
antagonists in ischaemic stroke; mortality data // Cerebrovasc.
Dis. - 1998. - 8 (Suppl. 4). - 27.
81. Hornig C.R., Dorndorf W., Agnoli A.L. Hemorrhagic cerebral
infarction - a prospective study // Stroke. - 1986. - 17. - P.
179-185.
82. Horning C.R., Buttner T., Hufnagel A. et al. Epileptic
seizures following ischemic cerebral infarction. Clinical picture,
CT findings, and prognosis // Europ. Arch. Psychiatry Neirol. Sci.
- 1990. - 239. - P. 379-383.
83. Indredavik B., Bakke R.P. T., Slordabl S.A. et al. Stroke
unit treatment. 10-year follow-up // Stroke. - 1999. - 30. - P.
1524-1527.
84. Indredavik B., Slordahl S., Bakke F. et al. Stroke unit
treatment: long-term effects // Ibid. - 1997. - 28. - P. 1861 -
1866.
85. International Stroke Trial Collaborative Group. The
international stroke trial (IST): a randomised trial of aspirin,
heparin, both or neither among 19435 patients with acute ischaemic
stroke // Lancet. - 1997. - 349. - P. 1569-1581.
86. Italian Acute Stroke Study Group. Haemodilution in acute
stroke: results of the Italian Haemodilution trial // Ibid. -
1988. - 1. - P. 318-321.
87. Jorgensen H.S., Kammersgaard L.P., Houth J. et al. Who
benefits from treatment and rehabilitation in a stroke unit? (A
community-based study) // Stroke. - 2000. - 31. - P. 434-439.
88. Kalra L., Evans A., Perez I. et al. Does caregives
training and support in stroke reduce costs of care? //
Cerebrovasc. Dis. - 2003. - 16 (Suppl. 4). - P. 123.
89. Kay R., Wong J., Yu Y. et al. LMWH for the treatment of
acute ischemic stroke // N. Engl. J. Med. - 1995. - 333. - P.
1588-1593.
90. Leonardi-Bee J., Bath P., Phillips S.J. et Sandercock P.
Blood pressure and clinical outcomes in the International Stroke
Trial // Stroke. - 2002. - 33. - P. 1315-1320.
91. Mohr J., Orgogozo J.M., Harrison M.J. G. et al.
Metaanalysis of oral nimodipine trials in acute ischemic stroke //
Cerebrovasc. Dis. - 1994. - 4. - P. 197-203.
92. Muir K.W., Lees K.R. A randomized, double-blind,
placebo-controlled pilot trial of intravenous magnesium in acute
stroke // Stroke. - 1995. - 26. - P. 1183-1186.
93. Ogawa A., Yoshimoto T., Kikuchi H. et al. Ebselen in acute
middle cerebral artery occlusion: a placebo-controlled,
double-blind clinical trial // Cerebrovasc. Dis. - 1999. _ 9. - P.
112-118.
94. Okada Y., Yamaguchi T., Minematsu K. et al. Hemorrhagic
transformation in cerebral embolism // Stroke. - 1989. - 20. - P.
598-603.
95. Patel A., Knapp M., Perez I. et al. Alternative strategies
for stroke care: cost-effectiveness analysis from a prospective
randomized controlled trial // Cerebrovasc. Dis. - 2003. - 16
(Suppl.4). - P. 101.
96. Prasad K., Shirivastava A. Surgery for primary
supra-tentorial intracerebral haemorrhage //In: The Cochrane
Library, Issue 3, 2000.. Oxford: Update Software. Search date
August 1998.
97. PROGRESS Collaborative Group. Randomised trial of a
perindopril-based blood-pressure-lowering regimen among 6105
individuals with previous stroke or transient ischaemic attack //
Lancet. - 2001. - 358. - P. 1033-1041.
98. Ricci S., Celani M.G., Cantisani A.T., Righetti E.
Piracetam for acute ischaemic stroke // In: The Cochrane Library,
Issue 3, 2000. Oxford: Update Software. Search date January 1999.
99. Rieke K., Krieger D., Adams H.P. et al. Therapeutic
strategies in spice-occupaying cerebellar infarction based on
clinical, neuroradiological and neurophysiological data //
Cerebrovasc.Dis. - 1993. - 3. - P. 45-55.
100. Rogers A., MacMahon S., Gambl G. Blood pressure and risk
of stroke patients with cerebrovascular disease // BMJ. - 1996. -
313. - P. 147.
101. Scandinavian Stroke Study Group. Multicenter trial of
hemodilution in acute ischemic stroke: results in the total
patients population // Stroke. - 1987. - 18. - 691-699.
102. Schrader J., Rothermeyer M., Luders S., Kollmann K.
Hypertension and stroke - rationale behind the ACCESS trial //
Basic Res. Cardiol. - 1998. - 93 (Suppl. 2). - P. 69-78.
103. Schrader J., Luders S., Kulschewski A. et al. The ACCESS
study. Evaluation of Acute Candesartan Cilexitil Therapy in Stroke
Survivors // Stroke. - 2003. - 3-4. - P. 1699-1703.
104. Sherman D.G. For the STAT writers group.
Defibrinogenation with viprinex (Ancrod) for the treatment of
acute ischemic stroke // Stroke. 1999. - 30. - Abstr: 234.
105. Stroke Unit Trialists Collaboration. Organised inpatient
(stroke unit) care for stroke // In: The Cochrane Library,, Issue
3, 2000. Oxford: Update Software. Search date June 1998.
106. Stroke Units Trialists Collaboration. A systematic review
of the randomized trials of organised impation (stroke unit) care
after stroke // BMJ. - 1997. - 314. - P. 1151 - 1159.
107. Sulch D., Perez I., Melbourn A., Karla L. Randomized
controlled trial of integrated (managed) care pathway for stroke
rehabilitation // Stroke. - 2000. - 31. - P. 1929-1934.
108. Swanson R. Intravenous heparin for acute stroke. What can
we learn from the megatrialists? // Neurology. - 1999. - 52. -
P.:1746-1750.
109. Wahlgren N., MacMahon D.G., DeKeyser J. et al.
Intravenous Nimodipine West European Stroke Trial (INWEST) of
nimodipine in the treatment of acute ischemic stroke //
Cerebrovasc. Dis. - 1994. - 4. - P. 204-210.
110. Wardlaw J., Warlow C. Thrombolytic therapy for acute
ischaemic stroke - the update cochrane database of systematic
reviews meta-analysis // Ibid. - 1999. - 9. - P. 124.
111. Wardlaw J.M., del Zoppo G, Yamaguchi T. Thrombolysis for
acute ischaemic stroke // In The Cochhrane Library, Issue 3, 2000.
Oxford: Update Softtware. Search Date March 1999.
112. Warlow C.P., Dennis M.S., van Gijn J. et al. (Eds.). //
In: Treatment of primary intracerebral haemorrhage. In: Stroke: a
practical guide to management. Oxford: Blackwelll Science, 1996. -
P. 430-437.
113. White D.B., Norris J.W., Hachinski V.C., Lewis A. Death
in early stroke. Causes and mechanisms // Stroke. - 1979. - 10. -
P. 743.
|
